Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04267328 · ClinicalTrials.gov registry record
Post-Operative Cognitive Dysfunction in Normal Aging Patients Undergoing Elective Orthopedic Surgery
A clinical trial, sponsored by HealthPartners Institute.
- Completed
- Registry status
- 47
- Enrollment target
NCT04267328: Completed study, sponsored by HealthPartners Institute.
NCT04267328 is a clinical trial that has completed, run by HealthPartners Institute. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04267328 has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- 47 participants
- Enrollment target
Study Summary
Post-operative cognitive dysfunction (POCD) is a common concern for aging patients undergoing elective orthopedic surgery and significantly effects health outcomes. This study aims to evaluate the incidence of and risk factors associated with post-operative cognitive dysfunction in aging patients without prior history for mild cognitive impairment or dementia.
Primary Outcome
Defined as a decline of 1.5 or greater standard deviation on any one of the cognitive test performed from baseline to three-months post surgery. Score range: 0-100. A higher score indicates more cases of incident of POCD.
Interventions
- PROCEDURE Elective Orthopedic Surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2020-01-06 |
| Est. Completion | 2023-06-14 |
What the finished NCT04267328 record still lists
NCT04267328 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 47 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Elective Orthopedic Surgery is the first listed.
NCT04267328 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04267328 about?
NCT04267328 is a clinical study titled "Post-Operative Cognitive Dysfunction in Normal Aging Patients Undergoing Elective Orthopedic Surgery". Post-operative cognitive dysfunction (POCD) is a common concern for aging patients undergoing elective orthopedic surgery and significantly effects health outcomes. This study aims to evaluate the incidence of and risk factors associated with post-operative cognitive dysfunction in aging patients wi...
What is the current status of trial NCT04267328?
This trial is currently completed. The enrollment target is 47 participants. The study started on 2020-01-06. Estimated completion is 2023-06-14.
What interventions are being tested in trial NCT04267328?
The interventions under investigation include: Elective Orthopedic Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT04267328?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI